import React from 'react';
import {createFileRoute} from '@tanstack/react-router';
import {Site} from '@/components/BsgShell';
export const Route=createFileRoute('/insights/peptides-and-iron')({component:Article});
function Article(){return <Site><main>
<header className="paper-header"><div className="paper-header-inner">
<a href="/insights" className="paper-back">← Back to Insights</a>
<p className="paper-overline">SCIENTIFIC PERSPECTIVES / RESEARCH REVIEW</p>
<h1>Phosvitin-derived peptides and iron delivery</h1>
<p className="paper-deck">A research-focused review of egg-yolk phosvitin, functional phosphopeptides and their potential relevance to iron nutrition.</p>
<div className="paper-author"><img src="/assets/site/meletis-photo.jpg" alt="Portrait supplied for Dr. Chris D. Meletis"/><div><strong>Dr. Chris D. Meletis, ND</strong><span>Source commentary · Scientific perspectives</span></div></div>
</div></header>
<div className="paper-body"><aside className="paper-sidebar"><p>IN THIS ARTICLE</p><a href="#overview">The scientific question</a><a href="#peptides">Peptide fragments</a><a href="#evidence">Research gaps</a><a href="#clinical">Clinical context</a><a href="#references">References</a></aside>
<article className="paper-main">
<div className="paper-intro"><p><strong>Editorial source:</strong> “Harnessing the Power of Phosvitin Derived Peptides for Iron Delivery,” supplied as a manuscript by Dr. Chris D. Meletis, ND.</p></div>
<section id="overview"><p className="paper-section-tag">01 / BASIC SCIENCE</p><h2>The scientific question</h2>
<p>Egg-yolk phosvitin is highly phosphorylated and has strong interactions with minerals including iron. Its iron-binding properties are relevant when studying both egg yolk nutrition and the design of new peptide ingredients.</p>
<figure className="paper-figure"><img src="/assets/site/iron.svg" alt="Conceptual intestinal iron-handling illustration, not a demonstrated PepFerrin-specific absorption pathway"/><figcaption>Figure 1. Established intestinal iron physiology provides background; no PepFerrin™-specific uptake route is established by this diagram.</figcaption></figure></section>
<section id="peptides"><p className="paper-section-tag">02 / PEPTIDE CHEMISTRY</p><h2>Why fragments may differ</h2><p>Hydrolysing phosvitin produces smaller phosphorylated peptides. A 2011 review by Samaraweera and colleagues examines the potential of egg-yolk phosvitin as a source of bioactive phosphopeptides, including mineral-binding properties. This is a literature review, not a clinical trial of Ferravitin™ or PepFerrin™.</p></section>
<section id="evidence"><p className="paper-section-tag">03 / RESEARCH QUESTIONS</p><h2>What remains unknown</h2><p>The possibility that specific phosphopeptides alter iron solubility or delivery should be explored with analytical characterization, validated absorption models and controlled human studies. A mechanism of action or clinically important human absorption advantage for PepFerrin™ has not been established by the references below.</p>
<div className="paper-key-point"><strong>What we know so far</strong><p>Mineral binding and human bioavailability are distinct research questions. Product-specific absorption, comparative tolerability and clinical outcomes require controlled investigation.</p></div></section>
<section id="clinical"><p className="paper-section-tag">04 / CLINICAL CONTEXT</p><h2>Clinical and regulatory context</h2><p>Oral iron tolerability varies by formulation and dose. General literature about adverse events with oral iron should not be treated as direct evidence that Ferravitin™ causes fewer adverse events. The existing nine-person internal observation is uncontrolled and is not presented as clinical proof.</p></section>
<section id="references"><p className="paper-section-tag">05 / SOURCES</p><h2>Selected references</h2><ol className="paper-references">
<li>Samaraweera H, Zhang W-G, Lee EJ, Ahn DU. Egg yolk phosvitin and functional phosphopeptides—review. <em>Journal of Food Science.</em> 2011;76(7):R143–R150. <a href="https://doi.org/10.1111/j.1750-3841.2011.02291.x" target="_blank" rel="noopener noreferrer">View publication ↗</a></li>
<li>NIH Office of Dietary Supplements. <a href="https://ods.od.nih.gov/factsheets/Iron-HealthProfessional/" target="_blank" rel="noopener noreferrer">Iron — Health Professional Fact Sheet ↗</a></li>
<li>Health Canada. <a href="https://health-products.canada.ca/lnhpd-bdpsnh/info?licence=80143362" target="_blank" rel="noopener noreferrer">Daily Maintenance NPN 80143362 ↗</a> and <a href="https://health-products.canada.ca/lnhpd-bdpsnh/info?licence=80143356" target="_blank" rel="noopener noreferrer">Pregnancy Formula NPN 80143356 ↗</a>.</li>
</ol></section>
<div className="paper-endnote"><strong>Editorial note</strong><p>The submitted Meletis manuscript is distinguished from independently published research. Preliminary N=9 observational data are not evidence of product-specific clinical superiority.</p></div>
</article></div>
</main></Site>}
